Total planned funding: $370,027,216
Clear active filters
Namibia
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
| Namibia | $370,027,216 |
Organizational Types
| NGO | $96,764,290 |
| Private Contractor | $67,865,288 |
| Host Country Government Agency | $64,169,315 |
| Own Agency | $52,010,681 |
| University | $34,834,963 |
| Unknown | $34,415,169 |
| Parastatal | $6,048,031 |
| Other USG Agency | $4,695,816 |
| Implementing Agency | $3,932,934 |
| FBO | $3,450,729 |
| Multi-lateral Agency | $1,840,000 |
Program Areas
| Treatment | $100,611,268 |
| Prevention | $72,958,071 |
| Care | $70,854,977 |
| Governance and Systems | $60,768,632 |
| Management and Operations | $37,179,447 |
| Testing | $27,654,821 |
Budget Codes
| HTXS: Treatment: Adult Treatment | $81,562,361 |
| HVMS: Management and Operations | $37,179,447 |
| OHSS: Health Systems Strengthening | $31,904,265 |
| HKID: Care: Orphans and Vulnerable Children | $29,437,497 |
| HVCT: Testing: HIV Testing and Counseling | $27,654,821 |
| HBHC: Care: Adult Care and Support | $22,736,111 |
| HVSI: Strategic Information | $22,311,443 |
| HVOP: Sexual Prevention: Other Sexual Prevention | $21,776,997 |
| HVAB: Sexual Prevention: Abstinence/Be Faithful | $20,690,484 |
| MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $14,719,571 |
| HVTB: Care: TB/HIV | $12,696,044 |
| HTXD: Treatment: ARV Drugs | $11,537,089 |
| CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $9,479,665 |
| PDTX: Treatment: Pediatric Treatment | $7,511,818 |
| HLAB: Laboratory Infrastructure | $6,552,924 |
| PDCS: Care: Pediatric Care and Support | $5,985,325 |
| HMBL: Biomedical Prevention: Blood Safety | $4,133,898 |
| HMIN: Biomedical Prevention: Injection Safety | $2,157,456 |
Top Partner Programs
USG Aggregated Agencies:
$38,778,992
Countries/Regions
Potentia Namibia:
$38,471,066
Countries/Regions
Not Available:
$32,843,511
Countries/Regions